http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100522337-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C271-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C269-06
filingDate 1997-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2005-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-100522337-B1
titleOfInvention Process for the Preparation of NMDA Antagonists
abstract The present invention provides an improvement of a known amine compound of formula (I) useful as a drug comprising reacting a compound of formula (II) with a compound of formula (III) followed by deprotection and optionally forming a pharmaceutically acceptable salt It provides a prepared method.n n n <Formula I>n n n n n n n n <Formula II>n n n n n n n n <Formula III>n n n n n n n n In the above formula,n n n R 1 and R 2 are independently phenyl or 4-fluorophenyl,n n n R 3 is hydrogen, C 1-4 alkyl or methoxycarbonyl,n n n R 4 is hydrogen or methyl,n n n R 5 , R 6 , R 7 , R 8 , R 9 and R 10 are independently C 1-6 alkyl.
priorityDate 1996-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410510994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394866
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419768771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421460509
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454125785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID78288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421455621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10893933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449549125
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19907804

Total number of triples: 49.